We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 36.50 | 35.00 | 38.00 | 36.50 | 36.50 | 36.50 | 105,000 | 08:00:00 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/1/2017 21:26 | mustau, what rights do the adr's not have? I know they are not fungible. | greg the grinch | |
04/1/2017 16:25 | Up again today | someuwin | |
03/1/2017 15:07 | These may not be on parity with the Bangladesh exchange shares, but will still rise (and fall) in a similar fashion. If the company keeps growing, which I expect as exports increase exponentially the the share price will continue to move up. | someuwin | |
03/1/2017 14:35 | They do have rights but not to the extent of ordinary shares, dual listing should have been done in the first place. 30% differential between Bangla and here. | mustau | |
03/1/2017 13:43 | How can they fix that then. A proper dual listing? | zcaprd7 | |
03/1/2017 11:46 | Theses are GDR'S and not ordinary shares here, markets here will suppress value as these will have no rights. | mustau | |
03/1/2017 09:49 | For those who missed this tip just before xmas... | someuwin | |
03/1/2017 09:27 | Looks like not much stock available. | someuwin | |
03/1/2017 09:11 | Started a new thread with more detail in the header. Will add more later. | someuwin | |
03/1/2017 09:10 | "Beximco Pharmaceuticals Ltd (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around the world. Beximco Pharma is consistently building upon its portfolio and currently producing more than 500 products encompassing broad therapeutic categories and the Company has created strong differentiation by offering a range of high-tech, specialized products which are difficult to imitate." Links: * * * | someuwin | |
30/12/2016 11:54 | Closing on a new high here will bode well for 2017. | someuwin | |
30/12/2016 10:55 | Cash divi is very small about £4 for a year on 1000shares and stock divi that used to be 20 per cent now small too but look how much the share price has gone up.You have to be positive in your thinking combined with a healthy scepticism methinks | 4spiel | |
30/12/2016 10:36 | what is the dividend payment guys ? Stockopedia doesn't seem to have it shown. | panic investor | |
30/12/2016 10:34 | Dividend has been credited today In HL account | neurolodger | |
30/12/2016 10:30 | They have always paid the dividends in the past but they sure take their time parting with them! This has in past been a very controversial share with much expressed suspicion of the management of this which seems to be part of a larger conglomerate of companies in Bangladesh. Also the GDR status of this security has been much commented upon as its separate from the Dhakka listed stock.However this is not unusual and what is in favour of this company is that it has been outperforming. When there is a strong momentum all is usually well - need to watch out more if things go sour. But speculation this could become a new Glaxo.In Bangladesh it is still cheap to employ people that's why so many come here if only to scratch a living in curry kitchens and housing benefit ! Not the only ones of course. Those who piled in when these shares were 5p have done well - long way to catch up with Glaxo but might 500p be achievable in a few years ? | 4spiel | |
30/12/2016 10:19 | Global ageing poulations require more and more medicines. Most (all?) heath budgets are being overloaded. BXP provides generic drugs at affordable prices. Exporting to over 50 countries. More than 300 generic medicines. "...the broad portfolio encompasses all key therapeutic categories including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, gastrointestinal etc." | someuwin | |
30/12/2016 09:56 | High growth and low PER. The perfect combination. | someuwin | |
30/12/2016 09:27 | This news released just a few weeks back went largely unnoticed. This share price needs a serious re-rating imo. "19 December 2016 BEXIMCO PHARMACEUTICALS LIMITED US FDA approves extended-release Metformin for diabetes control Third product approval for the US market Beximco Pharmaceuticals Limited ("Beximco Pharma" or "the Company"; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, and Bangladesh's leading exporter of pharmaceutical products, today announces that it has received approval for its Metformin Hydrochloride extended-release tablets (500 mg and 750 mg) from the US Food and Drug Administration (US FDA). This product is the generic equivalent to Bristol-Myers Squibb's (BMS) Glucophage XR tablets (500 mg and 750 mg). Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Annual sales for Glucophage XR in the US were $918 million for the twelve months ending 31 October 2016, according to IMS data. This is Beximco's third Abbreviated New Drug Application (ANDA) approval since the Company's oral solid dosage facility was approved by the US FDA in June 2015." | someuwin | |
30/12/2016 08:54 | x-o owned by jarvis. | greg the grinch | |
30/12/2016 08:54 | rogash: jarvis x-o here hxxp://www.x-o.co.uk | greg the grinch | |
30/12/2016 08:50 | I am with HL no sign of dividend. | neurolodger | |
30/12/2016 08:21 | Can't get a buy quote for more than £2k's worth. | someuwin | |
30/12/2016 07:18 | Thanks firtashia. Do you mean Jarvis Securities (JIM)? How do you find them? I believe the ex divi date was 28/10/16. | rogash | |
29/12/2016 21:37 | November wasn't it. Not very clear with the stock and cash dividends. Based on par value not share price value, etc etc. Still waiting with Hargreaves for both... | zcaprd7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions